Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROCK inhibitor for corneal endothelial protection in Fuchs' endothelial corneal dystrophy after cataract surgery
TCTR20220602005Phase 3Unknown
- Sponsor
- The 90th Anniversary of Chulalongkorn University Fund
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ROCK inhibitor in Fuchs endothelial dystrophy (FED), sponsored by The 90th Anniversary of Chulalongkorn University Fund. Status: unknown.
02
Drugs
ROCK inhibitor
03
Conditions
Fuchs endothelial dystrophy (FED)
Beyond the preview
Go deeper on TCTR20220602005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220602005.